PL371439A1 - Pochodne ftalimidu jako inhibitory monoaminoksydazy B - Google Patents
Pochodne ftalimidu jako inhibitory monoaminoksydazy BInfo
- Publication number
- PL371439A1 PL371439A1 PL03371439A PL37143903A PL371439A1 PL 371439 A1 PL371439 A1 PL 371439A1 PL 03371439 A PL03371439 A PL 03371439A PL 37143903 A PL37143903 A PL 37143903A PL 371439 A1 PL371439 A1 PL 371439A1
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- monoamine oxidase
- phthalimido derivatives
- phthalimido
- derivatives
- Prior art date
Links
- 102000010909 Monoamine Oxidase Human genes 0.000 title 1
- 108010062431 Monoamine oxidase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000005544 phthalimido group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02007222 | 2002-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL371439A1 true PL371439A1 (pl) | 2005-06-13 |
Family
ID=28051746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03371439A PL371439A1 (pl) | 2002-03-27 | 2003-03-20 | Pochodne ftalimidu jako inhibitory monoaminoksydazy B |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6660736B2 (pl) |
| EP (1) | EP1490334A1 (pl) |
| JP (1) | JP4202270B2 (pl) |
| KR (1) | KR100592630B1 (pl) |
| CN (1) | CN1277820C (pl) |
| AR (1) | AR039122A1 (pl) |
| AU (1) | AU2003226680B2 (pl) |
| BR (1) | BR0308786A (pl) |
| CA (1) | CA2477771A1 (pl) |
| MX (1) | MXPA04009335A (pl) |
| PL (1) | PL371439A1 (pl) |
| RU (1) | RU2317289C2 (pl) |
| WO (1) | WO2003080573A1 (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6846832B2 (en) * | 2002-08-07 | 2005-01-25 | Hoffman-La Roche Inc. | 2,3-dihydro-isoindol-1-one derivatives |
| AU2004283452A1 (en) * | 2003-10-23 | 2005-05-06 | F. Hoffmann-La Roche Ag | Benzazepine derivatives as MAO-B inhibitors |
| WO2006090228A1 (en) * | 2005-02-22 | 2006-08-31 | Mcgill University | Oxidative stress measurement device and related methods |
| KR20070094666A (ko) | 2005-02-25 | 2007-09-20 | 에프. 호프만-라 로슈 아게 | 약제 물질 분산성이 향상된 정제 |
| TW200804347A (en) | 2006-01-10 | 2008-01-16 | Janssen Pharmaceutica Nv | Urotensin II receptor antagonists |
| WO2008016534A1 (en) | 2006-07-31 | 2008-02-07 | Janssen Pharmaceutica, N.V. | Urotensin ii receptor antagonists |
| KR101669432B1 (ko) * | 2007-08-27 | 2016-10-26 | 다트 뉴로사이언스 (케이만) 엘티디. | 치료적 이속사졸 화합물 |
| ATE546448T1 (de) * | 2008-08-02 | 2012-03-15 | Janssen Pharmaceutica Nv | Urotensin-ii-rezeptorantagonisten |
| US20160362391A1 (en) * | 2013-11-25 | 2016-12-15 | Mylan Laboratories Ltd. | Improved Process for the Preparation of Pomalidomide and its Purification |
| CN107709314A (zh) | 2015-06-11 | 2018-02-16 | 巴斯利尔药物国际股份公司 | 外排泵抑制剂及其治疗性用途 |
| CN106188039B (zh) * | 2016-06-30 | 2019-01-01 | 广东工业大学 | 一种二酮衍生物及其制备方法与应用 |
| CA3035999C (en) * | 2017-09-07 | 2021-01-05 | Syaulan S. YANG | Benzene fused heterocyclic derivatives and pharmaceutical composition comprising the same |
| CN108752300B (zh) * | 2018-05-16 | 2022-03-25 | 中国科学院昆明植物研究所 | 苄烯叉苯肽类化合物及其药物组合物和其应用 |
| CN111072604B (zh) * | 2018-10-18 | 2022-11-04 | 广东东阳光药业有限公司 | α-氨基酰胺衍生物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4524206A (en) | 1983-09-12 | 1985-06-18 | Mead Johnson & Company | 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives |
| JPH04295470A (ja) | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法 |
| TW219935B (pl) * | 1991-12-25 | 1994-02-01 | Mitsubishi Chemicals Co Ltd | |
| ES2208690T3 (es) * | 1994-08-30 | 2004-06-16 | Sankyo Company Limited | Isoxazol. |
| US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
| EP0906090A1 (en) | 1996-03-15 | 1999-04-07 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neurophathy by administering selegiline |
| AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-03-13 US US10/387,950 patent/US6660736B2/en not_active Expired - Fee Related
- 2003-03-20 CA CA002477771A patent/CA2477771A1/en not_active Abandoned
- 2003-03-20 MX MXPA04009335A patent/MXPA04009335A/es active IP Right Grant
- 2003-03-20 RU RU2004131651/04A patent/RU2317289C2/ru not_active IP Right Cessation
- 2003-03-20 BR BR0308786-7A patent/BR0308786A/pt not_active IP Right Cessation
- 2003-03-20 EP EP03744825A patent/EP1490334A1/en not_active Withdrawn
- 2003-03-20 JP JP2003578328A patent/JP4202270B2/ja not_active Expired - Fee Related
- 2003-03-20 AU AU2003226680A patent/AU2003226680B2/en not_active Ceased
- 2003-03-20 CN CNB038070960A patent/CN1277820C/zh not_active Expired - Fee Related
- 2003-03-20 PL PL03371439A patent/PL371439A1/pl not_active Application Discontinuation
- 2003-03-20 KR KR1020047015131A patent/KR100592630B1/ko not_active Expired - Fee Related
- 2003-03-20 WO PCT/EP2003/002931 patent/WO2003080573A1/en not_active Ceased
- 2003-03-25 AR ARP030101023A patent/AR039122A1/es unknown
- 2003-09-09 US US10/657,857 patent/US6903095B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003226680A1 (en) | 2003-10-08 |
| AU2003226680B2 (en) | 2009-05-07 |
| KR100592630B1 (ko) | 2006-06-26 |
| RU2004131651A (ru) | 2005-07-10 |
| CN1277820C (zh) | 2006-10-04 |
| EP1490334A1 (en) | 2004-12-29 |
| WO2003080573A1 (en) | 2003-10-02 |
| MXPA04009335A (es) | 2005-01-25 |
| CN1642911A (zh) | 2005-07-20 |
| AR039122A1 (es) | 2005-02-09 |
| US20030195208A1 (en) | 2003-10-16 |
| KR20040108688A (ko) | 2004-12-24 |
| US20040229871A1 (en) | 2004-11-18 |
| RU2317289C2 (ru) | 2008-02-20 |
| JP2005526796A (ja) | 2005-09-08 |
| US6660736B2 (en) | 2003-12-09 |
| JP4202270B2 (ja) | 2008-12-24 |
| US6903095B2 (en) | 2005-06-07 |
| BR0308786A (pt) | 2005-01-11 |
| CA2477771A1 (en) | 2003-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1551801A4 (en) | NOVEL GAMMA-LACTAMES AS INHIBITORS OF BETA-SECRETASE | |
| EP1549316A4 (en) | HAMMER OF TFGbeta | |
| SI1492785T1 (sl) | 2-hidroksi-3-heteroarilindolni derivati kot inhibitorji GSK3 | |
| PL370478A1 (pl) | Pochodne aminoindazolu jako inhibitory kinaz białkowych | |
| AU2003261434A8 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
| IL236013A0 (en) | Adamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase type 1 enzyme inhibitors | |
| AU2003256334A8 (en) | Inhibitors of hcv upjohn company | |
| IL169691A0 (en) | Malonamide derivatives as gamma-secretase inhibitors | |
| AU2003293356A8 (en) | Dihydropyridinone derivatives as hne inhibitors | |
| HRP20041087A2 (en) | N-acylaminobenzene derivatives as selective monoamine oxidase b inhibitors | |
| IS7509A (is) | Þíoxantínafleiður sem mergperoxídasatálmar | |
| PL371439A1 (pl) | Pochodne ftalimidu jako inhibitory monoaminoksydazy B | |
| PL374279A1 (pl) | Nitrooksypochodne inhibitorów cyklooksygenazy-2 | |
| AU2003239508A8 (en) | Indole compounds useful as impdh inhibitors | |
| AU2003290735A1 (en) | Inhibitors of monoamine uptake | |
| AU2003230392A8 (en) | Beta-secretase inhibitors | |
| PL372226A1 (pl) | Pochodne pirydynoamidu jako inhibitory monoaminooksydazy (MAO-B) | |
| ZA200409691B (en) | Heterotricyclyl 6-alkylidene-penems as ß-lactamase inhibitors | |
| PL373523A1 (pl) | Indol-2-ony jako selektywne inhibitory cyklooksygenazy-2 | |
| AU2003295638A8 (en) | Novel inhibitors of beta-lactamase | |
| AU2003216848A1 (en) | Deracemisation of amines | |
| SI1487802T1 (sl) | 2,3-diaril-pirazolidinski derivati kot inhibitorji encimov, ki razgrajujejo nevrotenzin | |
| AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
| AU2003231527A8 (en) | Novel derivatives of carnosic acid | |
| HUP0203929D0 (en) | New use of substituted alkyl-piridazinone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |